GlaxoSmithKline Pakistan Limited (PSX:GLAXO)

GlaxoSmithKline Pakistan Revenue

GlaxoSmithKline Pakistan had revenue of 17.03B PKR in the quarter ending March 31, 2026, with 9.30% growth. This brings the company's revenue in the last twelve months to 67.35B, up 10.13% year-over-year. In the year 2025, GlaxoSmithKline Pakistan had annual revenue of 65.90B with 7.70% growth.

• Revenue (ttm): 67.35B
• Revenue Growth: +10.13%
• P/S Ratio: 1.69
• Revenue / Employee: 41.94M
• Employees: 1,606
• Market Cap: 114.13B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	65.90B	4.71B	7.70%
Dec 31, 2024	61.19B	11.53B	23.21%
Dec 31, 2023	49.66B	7.82B	18.69%
Dec 31, 2022	41.84B	5.18B	14.13%
Dec 31, 2021	36.66B	1.57B	4.48%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 8, 2026

Data Sources Report a data error